14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.58 $5.85 Friday, 3rd May 2024 CTMX stock ended at $4.43. This is 1.56% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 14.22% from a day low at $4.43 to a day high of $5.06.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
May 13, 2020 $14.86 $15.44 $13.72 $14.44 1 002 183
May 12, 2020 $14.46 $15.33 $14.46 $14.64 1 148 840
May 11, 2020 $14.21 $14.86 $13.47 $14.46 797 151
May 08, 2020 $12.84 $14.50 $12.45 $14.24 1 250 812
May 07, 2020 $12.23 $12.59 $11.95 $12.25 989 109
May 06, 2020 $11.68 $12.10 $11.27 $12.05 441 331
May 05, 2020 $11.68 $11.89 $11.43 $11.60 342 553
May 04, 2020 $11.16 $11.94 $10.91 $11.52 491 878
May 01, 2020 $10.09 $11.29 $9.85 $11.21 469 995
Apr 30, 2020 $10.94 $11.12 $10.14 $10.32 375 579
Apr 29, 2020 $8.67 $11.16 $8.63 $10.99 1 084 552
Apr 28, 2020 $9.43 $9.43 $8.73 $8.77 295 346
Apr 27, 2020 $9.47 $9.48 $9.03 $9.25 551 474
Apr 24, 2020 $9.23 $9.35 $8.70 $9.30 400 736
Apr 23, 2020 $9.53 $9.70 $9.20 $9.23 688 961
Apr 22, 2020 $10.27 $10.27 $9.31 $9.50 373 006
Apr 21, 2020 $9.45 $10.15 $9.38 $10.07 537 391
Apr 20, 2020 $9.35 $9.99 $9.15 $9.62 376 835
Apr 17, 2020 $9.46 $9.52 $8.85 $9.48 438 092
Apr 16, 2020 $8.89 $9.22 $8.51 $9.16 615 618
Apr 15, 2020 $8.46 $8.88 $8.39 $8.77 875 726
Apr 14, 2020 $8.90 $9.40 $8.65 $8.77 602 517
Apr 13, 2020 $8.54 $8.95 $8.21 $8.90 259 669
Apr 09, 2020 $8.67 $8.69 $8.32 $8.57 344 105
Apr 08, 2020 $7.90 $8.69 $7.68 $8.40 444 237
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT